Travel-associated illness trends and clusters, 2000-2010 by Leder, Karin et al.
Longitudinal data	 examining	 travel-associated	 illness	
patterns	are	 lacking.	To	address	 this	need	and	determine	
trends	 and	 clusters	 in	 travel-related	 illness,	we	examined	
data	 for	 2000–2010,	 prospectively	 collected	 for	 42,223	 ill	
travelers	by	18	GeoSentinel	sites.	The	most	common	desti-
nations	from	which	ill	travelers	returned	were	sub-Saharan	
Africa	 (26%),	 Southeast	 Asia	 (17%),	 south-central	 Asia	
(15%),	and	South	America	(10%).	The	proportion	who	trav-
eled	 for	 tourism	 decreased	 significantly,	 and	 the	 propor-
tion	 who	 traveled	 to	 visit	 friends	 and	 relatives	 increased.	
Among	 travelers	 returning	 from	malaria-endemic	 regions,	
the	 proportionate	 morbidity	 (PM)	 for	 malaria	 decreased;	
in	 contrast,	 the	 PM	 trends	 for	 enteric	 fever	 and	 dengue	
(excluding	 a	 2002	 peak)	 increased.	 Case	 clustering	 was	
detected	 for	 malaria	 (Africa	 2000,	 2007),	 dengue	 (Thai-
land	 2002,	 India	 2003),	 and	 enteric	 fever	 (Nepal	 2009).	 
This	multisite	 longitudinal	 analysis	 highlights	 the	 utility	 of	
sentinel	surveillance	of	travelers	for	contributing	information	
on	disease	activity	trends	and	an	evidence	base	for	travel	
medicine	recommendations.
International travel is markedly increasing. In 2010, an estimated 940 million tourists arrived at international 
destinations, more than twice the 435 million in 1990 (1). 
Trips to developing regions have risen from 31% of all 
travel in 1990 to 47% in 2010, and trips to the Asia–Pa-
cific region, Africa, and the Middle East have doubled in 
the past decade (1). Reasons for travel have also changed; 
from 1990 to 2010, trips for tourism decreased from 56% 
to 51%, and trips by those with ties to the destination coun-
try (travel for the purpose of visiting friends and relatives) 
increased from 20% to 27% (1,2).
More than half of international travelers to develop-
ing countries become ill during their trip, and ≈8% seek 
medical care for a travel-associated illness either during or 
after travel (3). Changes in travelers’ illnesses over time 
would be expected to reflect changing patterns of global 
travel destinations, changes in local disease epidemiology 
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in regions visited, and/or availability of preventive mea-
sures such as vaccination and chemoprophylaxis. To exam-
ine illness trends and clusters among travelers, we analyzed 
multisite longitudinal data collected by GeoSentinel sites 
during 2000–2010.
Materials and Methods
The GeoSentinel Surveillance Network (www.ge-
osentinel.org) is a global network of specialized travel and 
tropical medicine providers. It was established through the 
International Society of Travel Medicine and the US Cen-
ters for Disease Control and Prevention (CDC) (4). Since 
1997, data have been collected on illnesses imported across 
international borders by travelers and immigrants. GeoSen-
tinel sites have been added progressively over time; cur-
rently, 54 clinics in 26 countries contribute data (Figure 1). 
Information is recorded for demographics, travel history, 
reason for travel, clinical signs and symptoms, and diag-
nosis. All sites use the best available reference diagnostic 
tests and base the identification of country (or region) of 
illness acquisition on itinerary, known endemicity patterns, 
and incubation periods. GeoSentinel sites enter their de-
identified questionnaire-based information into a central 
SQL (structured query language) database. The GeoSen-
tinel data-collection protocol was reviewed by the institu-
tional review board officer at the CDC and was classified as 
public health surveillance, not as human subjects research 
requiring submission to institutional review boards.
The mix of patients and diagnoses reported by indi-
vidual GeoSentinel sites varies according to site location 
and clinic type (hospital or outpatient). To examine trends 
over time, we included only sites that consistently reported 
posttravel data throughout the 11-year period of interest. 
From these sites we examined inpatient and outpatient data 
for trends in demographics, reason for travel, and propor-
tionate morbidity (PM) for certain key diagnoses. Spe-
cific infections were included in analyses on the basis of 
clinical relevance plus sufficient case numbers (Table 1). 
PM is expressed as number of cases/1,000 ill travelers re-
turned from the region(s) of interest. Where model fit of the 
PM variation over time was adequate (assessed statistically 
as the proportion of variance explained by year and con-
sidered adequately fitted if the coefficient of determination 
[R2 statistic] was >50%), the rate of change in proportion 
was estimated by using linear regression with year as the 
independent variable and by using p value to assess the null 
hypothesis that there was no change over time. Statistical 
significance was set at p<0.05. Statistical procedures were 
performed by using Stata 10/IC for Windows (StataCorp 
LP, College Station, TX, USA).
Case clustering was assessed by using the scan statis-
tic on georeferenced data. Cases were georeferenced to the 
centroid of the likely country of acquisition, and rate esti-
mates were based on the total number of ill returned travelers 
from that country who visited GeoSentinel sites. Diseases 
examined–dengue, malaria, and enteric fever–were chosen 
because of clinical importance and relative frequency. The 
scan statistic uses a Poisson model to estimate the number 
of cases of each disease relative to the population returning 
from a given area. To encompass changes in season, the tem-
poral window was set to 3 months. The spatial window was 
set to a 1,000-km radius. The scan statistic was calculated by 
using SatScan 9.1.1 (Kulldorff M; Information Management 
Services Inc., Boston, MA, USA), and significance was as-
sessed by using 1,000 Monte Carlo simulations.
Results
Of 54 current GeoSentinel sites, 18 reported consis-
tently during 2000–2010: 12 sites in North America, 2 in 
Australasia, and 4 in Europe/Middle East. A total of 42,223 
ill returned travelers were reported and included in this 
study. The annual increase in patient numbers reported 
over the 11 years was statistically significant (+5%/year, 
p = 0.03).
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Figure	1.	GeoSentinel	
regions.	
Travel-associated	Illness	Trends,	2000–2010
Reason for Travel
Tourists comprised 63% of ill returned travelers over-
all, but over the study period, this proportion decreased by 
10% (p = 0.009). By contrast, the proportion of those who 
traveled to visit friends and relatives increased from 9.1% 
in 2000 to 16.3% in 2010 (p = 0.002). The proportion of 
ill returned business travelers and missionaries/volunteers 
remained unchanged (Figure 2, panel A); the proportion of 
patients who reported having received pretravel advice de-
clined, but not significantly (−5%, p = 0.07).
Destinations
The most common destinations from which ill trav-
elers returned were sub-Saharan Africa (26%), Southeast 
Asia (17%), south-central Asia (15%), and South America 
(10%) (Figure 2, panel B). Over the 11-year period, the 
proportion of those returning from south-central Asia in-
creased significantly (+5%, p = 0.028).
Diseases
Malaria
The most common sites for acquiring malaria were 
sub-Saharan Africa (77%), Oceania (6%), and south-cen-
tral and Southeast Asia (5% each). However, the PM for 
malaria was greater for ill travelers returning from Ocea-
nia (average 248 malaria cases/1,000 ill travelers from the 
region) than for those returning from sub-Saharan Africa 
(average 135 cases/1,000 travelers). In 2000, the overall 
PM for malaria was 68 cases/1,000 ill travelers, and during 
2000–2010, the rate decreased by an average of 30/1,000 
(p = 0.002) (Figure 3, panel A). Despite overall increasing 
visits to GeoSentinel sites during the study period, abso-
lute case numbers for malaria decreased (211 malaria cases 
reported in 2000; 151 in 2006, 124 in 2008, 189 in 2010) 
(Figure 3, panel B). The PM (and absolute case numbers) 
rose marginally during 2009–2010, compared with 2008, 
but did not negate the overall decreasing trend over the 
study period, which was most marked among ill travelers 
returning from Oceania (-204/1,000, p = 0.010), sub-Sa-
haran Africa (−68/1,000, p = 0.003), and Southeast Asia 
(-31/1,000, p = 0.005).
PMs for malaria caused by Plasmodium falciparum 
and P. vivax decreased (-13/1,000, p = 0.012, and -13/1,000, 
p = 0.001, respectively). At a regional level, PMs for falci-
parum malaria decreased among ill travelers returning from 
sub-Saharan Africa (-39/1,000, p = 0.010), and PMs for 
vivax malaria decreased among those returning from Ocea-
nia (-169/1,000, p = 0.005), sub-Saharan Africa (-19/1,000, 
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Table	1.	Major	diagnoses	for	returning	travelers	visiting	18	
GeoSentinel	sites,	2000–2010* 
Diagnosis No.	cases 
Malaria 1,762 
Giardiasis 1,296 
Dengue	fever 888 
Campylobacteriosis 596 
Cutaneous	larva	migrans 577 
Rabies	postexposure	prophylaxis 349 
Enteric fever† 262 
Spotted	fever	rickettsiosis 220 
Chikungunya 120 
Acute	hepatitis	A 94 
Confirmed	influenza	A/B 84 
*Other	diagnoses	included	nonspecific	gastrointestinal	or	diarrheal	
syndromes	(25%	of	all	patients);	nonspecific	febrile	illness	or	viral	
syndrome	(10%);	rash,	itch,	or	skin	infection	(10%);	respiratory	
syndrome	(5%);	and	other	infectious	and	noninfectious	problems. 
†Salmonella enterica serovar	Typhi,	S. enterica ser.	Paratyphi,	or	
unspecified. 
 
Figure	2.	A)	Reason	 for	 travel	among	42,223	 ill	 returned	GeoSentinel	patients,	2000–2010.	Reason	 for	 travel	missing	 for	188	(0.4%)	
patients.	B)	Destinations	of	travel	among	42,223	ill	returned	GeoSentinel	patients,	2000–2010.	Region	missing	or	unable	to	be	determined	
(>1	region	was	visited)	for	3,601	(8.5%)	patients.
RESEARCH
p < 0.001), and Southeast Asia (-24/1,000, p = 0.009). 
Decreasing PM trends for malaria were also small but sig-
nificant among ill returning tourists (-37/1,000, p<0.001), 
travelers who visited friends and relatives (-103/1,000, p = 
0.011), and business travelers (−43/1,000, p = 0.007).
Enteric Fever
For enteric fever (caused by Salmonella enterica se-
rovar Typhi, S. enterica ser. Paratyphi, or unspecified), 
67% of cases were imported from south-central Asia and 
10% from each of Southeast Asia and sub-Saharan Africa 
(Figure 4). The PM for enteric fever increased over the 11 
years (+10/1,000, p = 0.013). Exclusion of the 2009 clus-
ter (Table 2) did not negate the overall significant trend. 
Regional trends could not be assessed because of consider-
able year-to-year variation in PM by region. Tourism ac-
counted for 55% of cases and travel to visit friends and 
relatives for 27%.
Dengue
With regard to dengue, 50% of patients had visited 
Southeast Asia; 17% south-central Asia; 9%–10% each 
Central America, South America, or the Caribbean; and 5% 
sub-Saharan Africa. There was considerable year-to-year 
PM variation not accounted for by a linear trend, largely be-
cause of a clear peak in 2002 (associated with an outbreak in 
Thailand) (6) (Figure 5). Excluding this peak, the underlying 
dengue PM (+26/1,000, p = 0.006) and case numbers (26 in 
2000, 169 in 2010) increased significantly, especially among 
ill travelers returning from Southeast Asia (+71/1,000, p = 
0.004) and sub-Saharan Africa (+8/1,000, p = 0.005).
Other
For chikungunya, the PM for total infections increased, 
as did the PM for cases acquired in Southeast Asia and 
south-central Asia. However, variation in PM was not well 
accounted for by a linear trend either overall or by region 
(Figure 6, panel A). 
The PM for confirmed influenza A or B also in-
creased. Similar to chikungunya, the variation in PM was 
not well accounted for by a linear trend, mostly because 
of the high number of visits during the 2009 pandemic 
(Figure 6, panel B). 
 The PM for rabies postexposure prophylaxis (PEP) 
increased significantly (+153/1,000, p<0.001) (Figure 6, 
panel C), particularly among those returning from South-
east Asia (+49/1,000, p = 0.001). No significant trends 
were found for hepatitis A, campylobacteriosis, giardiasis, 
cutaneous larva migrans, or spotted fever rickettsiosis.
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Figure	3.	A)	Proportionate	morbidity	(PM)	for	malaria	(no.	malaria	
cases/1,000	 ill	 returned	 GeoSentinel	 patients)	 by	 region,	 2000–
2010.	B)	Absolute	case	numbers	and	proportionate	morbidity	 for	
malaria	(no.	malaria	cases/1,000	ill	returned	GeoSentinel	patients)	
after	 travel	 to	sub-Saharan	Africa,	2000–2010.	There	were	1,363	
total	 reported	cases	of	malaria	after	 travel	 to	sub-Saharan	Africa	
among	the	18	GeoSentinel	sites.
Figure	4.	Proportionate	morbidity	(PM)	for	enteric	fever	(no.	enteric	 
fever	 cases/1,000	 ill	 returned	 GeoSentinel	 patients)	 by	 region,	
2000–2010.
Travel-associated	Illness	Trends,	2000–2010
Cluster analyses were performed only for malaria, en-
teric fever, and dengue. Results are shown in Table 2.
Discussion
Sentinel surveillance of travelers is increasingly being 
recognized as an integral element for identifying emerg-
ing infections and disease outbreaks (7). However, the his-
torical absence of systematic longitudinal data on travelers 
means that there are no studies on long-term disease trends 
among travelers and no data on whether traveler impor-
tation of illness mirrors regional disease trends in local 
populations. GeoSentinel surveillance has been performed 
continuously for >10 years and enables examination of 
longitudinal disease trends and clusters among returning 
ill travelers.
This 11-year analysis of ≈42,000 returned ill travelers 
identified several significant findings. Almost 60% had vis-
ited sub-Saharan Africa, Southeast Asia, or south-central 
Asia, but the largest regional fluctuation was in south-cen-
tral Asia (+5%, p = 0.028). The proportions of ill tourists 
(-10%) and ill travelers who had visited friends and rela-
tives (+9%) changed inversely. Although those who visit 
friends and relatives are at high risk for many travel-related 
health problems, pretravel advice and adequate precautions 
are often lacking (8,9).
Trends in morbidity rates for individual illnesses 
among travelers are influenced by many factors, including 
changes in disease incidence in regions visited, variations 
in uptake of preventive measures, and diagnostic factors. 
We report PM for specific illnesses, which is additionally 
influenced by changes in the number of travelers seen at 
GeoSentinel sites for other illnesses; therefore, interpre-
tation of the longitudinal trends in PM requires caution. 
However, the proportion of the most common other ill-
nesses seen was consistent (±3%) over the study years. 
Moreover, the lack of significant trends over time for some 
diseases examined, the decreasing trends for some illness-
es, and the increasing trends for others suggest that these 
trends reflect real (albeit small) changes in the patterns and 
relative frequency of returned-traveler visits to specialist 
centers for these illnesses. In particular, the significant in-
crease in proportion of ill travelers returning with enteric 
fever or dengue or seeking rabies PEP suggests that these 
conditions might have rising relevance for clinicians car-
ing for ill returned travelers. For malaria, the average PM 
decreased significantly over the study period. Consistent 
regional trends were also seen, such as the high PMs for 
malaria among ill travelers returning from Oceania and 
sub-Saharan Africa, for enteric fever among those return-
ing from south-central Asia, and for dengue among those 
returning from Southeast Asia (Figure 7). We also found 
significant clusters for malaria, enteric fever, and dengue.
Examination of simultaneous global changes in ma-
laria epidemiology shows decreasing numbers of cases and 
deaths since 2000 (10,11). This decrease has been associ-
ated with increased funding for international malaria con-
trol, which has facilitated implementation of improved pre-
ventive and therapeutic interventions. Additionally, case 
numbers might have been overestimated, but they are now 
being rectified by increased use of rapid diagnostic tests 
(RDTs) and better case ascertainment.
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Table	2. Main	clusters	detected	among	GeoSentinel	patients,	2000–2010 
Diagnosis,	cluster Location	and	dates	of	clusters	 
Cases/no.	ill	travelers	(no.	
expected	cases,	p	value)	 Comments 
Malaria    
 Cluster	A Benin,	Togo,	Ghana,	Burkina	Faso,	
Nigeria,	Cote	d'Ivoire,	2007	mid	Jul–mid	
Oct 
44/185	(2.6, p<0.0001) 
 
No	definitive	outbreaks	discernible	on	
ProMED-mail	or	in	published	literature	
corresponding	to	these	clusters 
 Cluster	B Mauritania,	Western	Sahara,	Mali,	
Senegal,	2000	mid	Sep–mid	Oct 
19/53,	(0.5,	p<0.0001) 
Enteric	fever Nepal,	2009	Oct 5–20 24/40	(0.03,	p<0.0001) Associated	with	an	outbreak	of	
Salmonella paratyphi	A	among	Israeli	
travelers	to	Nepal	(5) 
Dengue    
Cluster	A Thailand,	2002	Apr–Jul 44/257	(1.7,	p<0.0001) Reported	in	(6) 
Cluster	B India,	2003	Sep–Nov 13/368	(0.9,	p<0.0001) 
 
Figure	 5.	 Proportionate	 morbidity	 (PM)	 for	 dengue	 (no.	 dengue	
cases/1,000	returned	GeoSentinel	patients)	by	region,	2000–2010.
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One question is whether the observed overall decreas-
ing trend in malaria PM is a travel medicine prevention suc-
cess, a reflection of declining risk at destinations, a result of 
changes in diagnostics, or a combination of factors. Changes 
in diagnostic tests at GeoSentinel sites over the past decade, 
specifically more routine use of RDTs, are unlikely to have 
had much influence on malaria diagnosis at these special-
ized sites where experienced microscopists are available. 
Even if sensitivity of malaria diagnosis has increased with 
use of RDTs, this increase would not explain the observed 
decline in malaria PM. Because rates of imported malaria 
cases among travelers are influenced by use of personal 
protective measures and chemoprophylaxis, the decrease 
in PM might be partly attributable to better tolerated and 
more targeted prophylaxis (such as atovaquone/proguanil, 
available since 2000). However, the declining average PM 
trend over the study period (-28/1,000 ill travelers) is also 
consistent with reported global epidemiologic trends (12) 
resulting predominantly from decreased falciparum malaria 
cases. PMs for both falciparum and vivax malaria decreased 
significantly among ill persons returning after travel for 
tourism, visits to friends and relatives, and business.
Since 2009, resurgence of malaria cases has been ob-
served in several African countries, including Rwanda, São 
Tomé and Príncipe, Zambia, and Cape Verde (10). Our 
data also showed a slight increase in malaria PMs over the 
past 2 years (Figure 3); this finding is consistent with Euro-
pean and US data on imported malaria PMs for 2008–2010 
(13,14) but in juxtaposition to the reported global decline 
in case numbers.
About three quarters of all malaria cases occur in Af-
rica (10); among cases reported here, 77% were acquired in 
sub-Saharan Africa. Case clustering was detected in 2000 
and 2007 among travelers with malaria returning from Afri-
ca, but a review of electronic reports and relevant literature 
revealed no definitive specific corresponding outbreaks.
S. enterica ser. Typhi and Paratyphi cause an estimat-
ed 20 million cases of enteric fever and 200,000–600,000 
deaths annually in disease-endemic countries; cases have 
been increasing globally (15). Growing drug resistance is 
compounding the associated public health problem (16,17). 
In industrialized countries, the proportion of travel-related 
cases has risen (17,18), particularly S. enterica ser. Paraty-
phi cases, which are not prevented by current typhoid fever 
vaccines. Our results showing that two thirds of cases were 
among ill travelers returning from south-central Asia and 
that enteric fever PM is increasing (+10/1,000, p = 0.013) 
are consistent with global trends (19,20).
In October 2009, cluster analysis for enteric fever de-
tected greater importation than expected among ill travelers 
returning from Nepal. This increase was associated with a 
large outbreak among travelers from Israel who were vac-
cinated for S. enterica ser. Typhi (Vi vaccine) but who con-
tracted S. enterica ser. ParatyphiA infection in a restaurant 
in Pokhara, Nepal (5).
Among GeoSentinel patients with dengue, 50% ac-
quired infection in Southeast Asia; the PM for dengue 
(adjusted for the 2002 outbreak) increased significantly. 
Worldwide each year, 50–100 million dengue infections 
occur (21), nearly 75% in Southeast Asia and the West-
ern Pacific region (22). In the past 50 years, reported in-
cidence has increased 30-fold; dengue has expanded into 
new countries and into urban settings (22,23) associated 
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Figure	6.	Proportionate	morbidity	 (PM)	(no.	cases/1,000	returned	
GeoSentinel	patients),	2000–2010.	A)	chikungunya,	B)	 influenza,	
and	C)	 rabies	postexposure	prophylaxis.	Trends	 for	chikungunya	
and	influenza	were	not	calculated	because	of	substantial	nonlinear	
year-to-year	variation.
Travel-associated	Illness	Trends,	2000–2010
with population growth, urbanization, development of peri-
urban slums, movement of virus by infected travelers, and 
improved diagnostic capabilities (21,24). The marked in-
crease in cases in dengue-endemic regions is also reflected 
by data reporting infection among international travelers; 
prospective seroconversion studies estimate attack rates 
among travelers to the tropics to be 1.0%–6.7% (25–28). 
However, improved awareness of dengue and improved di-
agnostics, especially with PCR and nonstructural protein 1 
antigen testing now being routinely available, might well 
underpin the observed trend in dengue diagnoses among 
ill returned travelers. Travelers have also been reported to 
serve as sentinels for dengue infection: GeoSentinel data 
showed that travel-related dengue reflected defined re-
gional seasonality, and natural annual oscillations of cases 
among populations in dengue-endemic regions were also 
observed among travelers to these regions (6). In 2002, an 
increase in travel-related dengue activity among GeoSen-
tinel patients returning from Thailand was noted before an 
outbreak was recognized by official Thailand surveillance 
data (6). Increased dengue cases among ill returned travel-
ers from south-central Asia in 2003 were also evident be-
fore official surveillance data were available. Not surpris-
ingly, cluster analyses detected these cases, but our results 
additionally represent long-term trends in dengue reflected 
by traveler surveillance data.
Our data suggest an increase in PM for chikungunya. 
Interest in chikungunya fever, long known to be endemic 
to tropical Africa and Asia, resurged in 2005–2006 when a 
large outbreak spread through the Indian Ocean islands and 
Asia–Pacific region (29,30). The continuing epidemic has 
affected populations in popular travel destinations; many 
imported cases among travelers have been reported (31).
The significant rise in the PM of persons seeking ra-
bies PEP, particularly ill travelers returning from South-
east Asia, might result from an increased absolute risk 
for animal bites or scratches, or from increased high-risk 
exposures, high-risk activities, or awareness of rabies risk 
among travelers resulting in more visits for PEP. Globally, 
the number of human rabies cases and deaths has decreased 
markedly over the past 20 years (32,33), but in parts of In-
donesia (e.g., Bali) and China, it has increased (34).
Influenza clearly peaked in 2009, coinciding with the 
influenza (H1N1) pandemic. Although the underlying trend 
was not formally examined, the observed increase in num-
ber of cases (Figure 6, panel B) might reflect a real rise in the 
proportion of travelers acquiring influenza or might reflect 
a lowered threshold for referral to specialized clinics and 
better access to confirmatory diagnostics during this period.
This study has limitations. The GeoSentinel Surveil-
lance Network captures data only on ill persons who visit 
specialized clinics, and these data do not represent all in-
ternational travelers. GeoSentinel data can therefore not be 
used to calculate absolute risk; PM calculations are per-
formed instead. PM is a complex measure and changes 
over time either because of changes in numbers of reported 
cases of the disease of interest or because of significant 
changes in other diagnoses. Patterns of travel also change 
over time and are influenced by political, economic, and 
cultural events. Consequently, interpretation of results is 
complex, and changes in PM reflect changes in the recog-
nized levels of the specific illnesses seen at specialized sites 
over time rather than changes in absolute risk for disease 
acquisition. Where relevant, comments regarding changes 
in numbers of cases have also been included to verify that 
changes in frequency of other diagnoses do not explain re-
ported PM trends. Because the relative case mix of patients 
and diagnoses differs by GeoSentinel site, analyses need to 
account for changes in visits to each site over time. Sub-
analyses were performed to ensure that no single site was 
unduly driving overall trends (data not shown). Because 
disease acquisition is affected by numbers of travelers to 
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Figure	 7.	 Regional	 results	 for	
malaria,	 enteric	 fever,	 and	
dengue.	 For	 malaria,	 the	 top	
region	 for	 acquisition	 was	
sub-Saharan	 Africa	 (77%),	
and	 the	 region	 with	 the	 top	
average	 proportionate	 morbidity	
(248/1,000	 ill	 travelers)	 and	 the	
greatest	 trend	 (-39/1,000,	 p	 =	
0.01)	Oceania.	For	enteric	fever,	
the	 top	 region	 for	 acquisition	
was	 south-central	 Asia	 (67%);	
regional	 trends	 were	 not	
assessed.	 For	 dengue,	 the	 top	
region	 for	 acquisition	 (50%)	 and	
the	highest	average	proportionate	
morbidity	and	trend	(+70.5/1,000,	
p	=	0.004)	was	Southeast	Asia.
RESEARCH
each destination, type and duration of travel, preventive 
measures implemented, and many other factors, traveler 
surveillance data would not be expected to precisely mirror 
trends in illness among host populations. 
Despite these limitations, the annual changes in PM, 
although small, showed statistically significant trends that 
correlate with regional trends in disease for many diagno-
ses examined. In particular, PM changes for 3 major travel-
related illnesses reflect global trends in disease epidemiolo-
gy; trends for malaria decreased and trends for enteric fever 
and dengue increased. When case numbers were sufficient, 
significant regional trends could also be detected. We have 
also shown that an algorithm for detecting case clusters can 
be used on longitudinal traveler surveillance data. These 
findings highlight how sentinel surveillance of travelers 
provides an additional layer in surveillance efforts that can 
be used to inform the international community about dis-
ease activity trends in disease-endemic areas. Additionally, 
the relative contribution of diagnoses among returned ill 
travelers from different regions provides useful informa-
tion for provision of health advice before and after travel.
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